We are live on
!
Find out more
AGM
Alpine Global Management Portfolio holdings
AUM
$668M
1-Year Est. Return
20.22%
This Fund
S&P 500
This Quarter
Est. Return
+14.93%
1 Year Est. Return
+20.22%
3 Year Est. Return
+100.14%
5 Year Est. Return
+103.13%
10 Year Est. Return
+677.44%
AUM
$301M
AUM Growth
-$127M
(-30%)
Cap. Flow
-$134M
Cap. Flow
% of AUM
-44.67%
Top 10 Holdings %
Top 10 Hldgs %
57.1%
Holding
842
New
352
Increased
28
Reduced
90
Closed
287
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$15.1M |
| 2 |
MYOV
Myovant Sciences Ltd.
MYOV
|
+$14.1M |
| 3 |
Cornerstone Strategic Value Fund
CLM
|
+$9.51M |
| 4 |
Albertsons Companies
ACI
|
+$3.96M |
| 5 |
Rivian
RIVN
|
+$3.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$56.5M |
| 2 |
Immunovant
IMVT
|
+$35.9M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$11.3M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$10.7M |
| 5 |
VMW
VMware, Inc
VMW
|
+$10M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.53% |
| 2 | Technology | 13.41% |
| 3 | Financials | 12.89% |
| 4 | Consumer Discretionary | 7.02% |
| 5 | Industrials | 4.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Marathon Digital Holdings
MARA
$4.51B
| $112K | 0.04% |
+32,832
| New | +$276K |
|
227
NeoGenomics
NEO
$2.04B
| $112K | 0.04% |
+12,071
| New | +$113K |
|
228
Novavax
NVAX
$1.22B
| $112K | 0.04% |
+10,906
| New | +$192K |
|
229
Protagonist Therapeutics
PTGX
$8.92B
| $112K | 0.04% |
+10,279
| New | +$86.7K |
|
|
TSVT
230
DELISTED
2seventy bio
TSVT
| $112K | 0.04% |
+11,930
| New | +$168K |
|
231
Citizens
CIA
$246M
| $111K | 0.04% |
52,257
| – | – |
|
|
OTLY
232
Oatly Group
OTLY
$460M
| $111K | 0.04% |
+3,202
| New | +$122K |
|
233
Virgin Galactic
SPCE
$329M
| $111K | 0.04% |
+1,598
| New | +$149K |
|
234
Tilray
TLRY
$572M
| $111K | 0.04% |
+4,128
| New | +$145K |
|
235
C4 Therapeutics
CCCC
$405M
| $110K | 0.04% |
+18,574
| New | +$154K |
|
236
Caribou Biosciences
CRBU
$150M
| $110K | 0.04% |
+17,442
| New | +$155K |
|
|
PTRA
237
DELISTED
Proterra Inc. Common Stock
PTRA
| $110K | 0.04% |
+29,297
| New | +$155K |
|
238
Adicet Bio
ACET
$84.7M
| $109K | 0.04% |
+762
| New | +$190K |
|
239
Groupon
GRPN
$1.06B
| $109K | 0.04% |
+12,762
| New | +$98.8K |
|
240
NIO
NIO
$12.1B
| $109K | 0.04% |
+11,196
| New | +$129K |
|
|
FIRY
241
Firy Inc
FIRY
$152M
| $109K | 0.04% |
+10,755
| New | +$198K |
|
|
RAD
242
DELISTED
Rite Aid Corporation
RAD
| $109K | 0.04% |
+32,586
| New | +$155K |
|
243
FuboTV Inc
FUBO
$253M
| $108K | 0.04% |
+5,165
| New | +$189K |
|
|
ME
244
DELISTED
23andMe Holding Co
ME
| $108K | 0.04% |
+2,511
| New | +$146K |
|
245
AST SpaceMobile
ASTS
$17.5B
| $107K | 0.04% |
+22,102
| New | +$133K |
|
246
Upland Software
UPLD
$13.6M
| $107K | 0.04% |
+1,504
| New | +$112K |
|
|
HUYA
247
Huya Inc
HUYA
$570M
| $106K | 0.04% |
+26,913
| New | +$68.2K |
|
|
AMAM
248
DELISTED
Ambrx Biopharma Inc
AMAM
| $106K | 0.04% |
+46,723
| New | +$53.4K |
|
249
Veritone
VERI
$97.6M
| $105K | 0.03% |
+19,809
| New | +$127K |
|
250
Community Health Systems
CYH
$391M
| $104K | 0.03% |
+24,044
| New | +$74K |
|
Similar funds
IACCIA
TAP
CWP
WSCM
AO
BCP
LCM
TGCMU
Alpine Global Management's Q4 2022 Portfolio in Review
As of Q4 2022, Alpine Global Management held 842 positions worth $301M, down 30% from $427M the previous quarter. Its ten largest holdings account for 57% of the portfolio.
Alpine Global Management withdrew a net $134M in Q4 2022, closing 287 positions and reducing 90 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $56.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 21% a quarter earlier, followed by Technology and Financials.
Against the trend, Alpine Global Management opened a new position in Tesla worth $9.84M.
- Alpine Global Management's largest Q4 2022 buy was Tesla: 79,871 shares worth $9.84M.
- Alpine Global Management added most to Cornerstone Strategic Value Fund in Q4 2022, an estimated $9.51M increase.
- Alpine Global Management's biggest Q4 2022 reduction was Immunovant, cutting an estimated $35.9M.
- Alpine Global Management fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $56.5M.
- Alpine Global Management's ten largest holdings make up 57% of its $301M portfolio in Q4 2022.
- Alpine Global Management opened 352 new positions and closed 287 in Q4 2022.
- Alpine Global Management's portfolio value fell 30% quarter-over-quarter to $301M.
Based on Alpine Global Management's 13F filing for Q4 2022, filed 14 Feb 2023.